Vai al contenuto principale della pagina
Titolo: | Evidence-based respiratory medicine / / edited by Peter Gibson ... [et al.] |
Pubblicazione: | London, : BMJ, 2005 |
Descrizione fisica: | 1 online resource (642 p.) |
Disciplina: | 616.20046 |
Soggetto topico: | Respiratory organs - Diseases |
Evidence-based medicine | |
Classificazione: | 44.84 |
Altri autori: | GibsonPeter, Dr. |
Note generali: | Description based upon print version of record. |
Nota di bibliografia: | Includes bibliographical references and index. |
Nota di contenuto: | Evidence-based Respiratory Medicine; Contents; Contributors; Acknowledgement to Cochrane Library; 1. Practising evidence-based respiratory medicine; 1.1 Introduction; 1.2 Diagnostic strategies; 1.2.1 Presenting symptoms; 1.2.2 Lung function testing; 1.2.3 Chest radiographic and computerized tomography patterns; 1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach; 1.2.5 Screening for lung cancer; 1.3 Therapeutics: general issues; 1.3.1 Adherence and self-management; 1.3.2 Corticosteroid-induced osteoporosis; 1.3.3 Helping people to stop smoking; 2. Asthma |
2.1 Acute exacerbations2.2 Chronic therapy: B-agonists,short-acting,long-acting B2-agonists; 2.3 Inhaled corticosteroids in the treatment of asthma; 2.4 Anti-leukotrienes; 2.5 Asthma education; 2.6 Non-pharmacological and complementary interventions to manage asthma; 2.7 Difficult asthma; 2.8 Novel therapies in asthma: long-acting B2 -agonists/inhaled corticosteroids; 3. Chronic obstructive pulmonary disease; 3.1 Chronic obstructive pulmonary disease -acute exacerbations; 3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy | |
3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease3.4 Combination of inhaled corticosteroids and long-acting B2 -agonists in chronic obstructive pulmonary disease; 3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease; 3.6 Lung volume reduction; 4. Infection; 4.1 Bronchitis and sinusitis; 4.2 Community-acquired pneumonia; 4.3 Pulmonary tuberculosis; 4.4 Influenza: vaccination and treatment; 4.5 Bronchiectasis; 4.6 Adult cystic fibrosis; 4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis | |
5. Respiratory failure/sleep-disordered breathing5.1 Respiratory rehabilitation; 5.2 Non-invasive ventilation in acute respiratory failure; 5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?; 5.4 The treatment of the obstructive sleep apnoea-hypopnoea syndrome; 5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease; 6. Diffuse lung disease/pleural disease/thromboembolism; 6.1 Diffuse lung disease; 6.1.1 The treatment of cryptogenic fibrosing alveolitis | |
6.1.2 Evidence-based approach to the treatment of sarcoidosis6.1.3 Hypersensitivity pneumonitis; 6.2 Pleural disease; 6.3 Therapy of pulmonary thromboembolism: an evidence-based approach; 6.4 Pulmonary hypertension; Index | |
Sommario/riassunto: | First major evidence-based text in adult respiratory medicineComprehensive, authoritative summary of the best treatments for the major respiratory diseasesCompiled by specialists from the Cochrane Airways Management GroupEasy-to-use format, with key clinical implications summarised in each chapterKept up-to-date online Compiled by specialists from the Cochrane Collaboration Airways Management Group, Evidence-based Respiratory Medicine is the first major evidence-based text in adult respiratory medicine. Providing a comprehensive summary of the best treat |
Titolo autorizzato: | Evidence-based respiratory medicine |
ISBN: | 1-280-74297-6 |
9786610742974 | |
0-470-79050-4 | |
0-470-98737-5 | |
1-4051-7237-1 | |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910877793003321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |